Home > Insider Trading > Filing (0001179110-15-002258)

Filing Details

Accession Number:: 0001179110-15-002258
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-02-10 17:31:27
Reporting Period:: 2015-02-06

Filing Date:: 2015-02-10
Accepted Time:: 2015-02-10 17:31:27
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
926326	Omnicell Inc	OMCL	Electronic Computers (3571)	943166458

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1271802	S Dan Johnston	C/O Omnicell, Inc. 590 E.middlefield Mountain View CA 94043	Executive Vp & General Counsel	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2015-02-06	3,333	$0.00	70,040	No	4	A	Direct
Common Stock	Acquisiton	2015-02-06	6,667	$0.00	76,707	No	4	A	Direct
Common Stock	Acquisiton	2015-02-06	2,500	$20.95	79,207	No	4	M	Direct
Common Stock	Acquisiton	2015-02-06	2,775	$7.94	81,982	No	4	M	Direct
Common Stock	Disposition	2015-02-06	2,500	$33.28	79,482	No	4	S	Direct
Common Stock	Disposition	2015-02-06	2,775	$33.29	76,707	No	4	S	Direct
Common Stock	Disposition	2015-02-06	1,277	$33.30	75,430	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	A	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Acquisiton	2015-02-06	10,000	$0.00	10,000	$34.02
Common Stock	Stock Option (Right to Buy)	Acquisiton	2015-02-06	2,500	$0.00	2,500	$20.95
Common Stock	Stock Option (Right to Buy)	Acquisiton	2015-02-06	2,775	$0.00	2,775	$7.94

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
10,000	2016-02-06	2025-02-05	No	4	A	Direct
7,500	2011-01-01	2017-02-07	No	4	M	Direct
8,100	2010-01-01	2019-02-04	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	66,707	Direct

Footnotes

Shares shall vest semiannually over 48 months.
Shares vest ratably over a 48 month period, with a 1 year cliff.
The performance-based restricted stock unit awards vest as to 25% of the shares on the date of the Compensation Committee meeting in 2016 when the Committee reviews the performance-based metrics and determines if they were met or not with the remaining shares vesting on a semi-annual basis over a period of thirty-six months commencing on June 15, 2016 if the Company meets certain stock performance objectives compared to the NASDAQ Healthcare Index. The actual number of performance based stock awards that vest may be 0%, 50% or 100% of the numbers reflected above, depending upon the Company's performance.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.96 to $33.49, inclusive. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.96 to $33.60, inclusive. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.96 to $33.46, inclusive. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.